ETH Zurich spinout Spirochem has raised cash to accelerate its sales activities and boost productivity.

NorthSea Therapeutics has secured $29.3m in series A funding to continue development of treatments for inflammatory and liver diseases.

Clas Ohlson has agreed to invest in e-commerce platform MatHem as part of a partnership agreement that will enable the latter to sell Clas Ohlson's goods.

Video advertising software developer Mirriad aims to raise $35m in a London initial public offering that will score exits for Unilever, STV and Zee Entertainment.

University of Surrey in-video advertising spinout Mirriad is set to raise $35m in an initial public offering at a market cap of $84.4m.

Gilead, Boehring Ingelheim and Takeda have contributed to a $59.6m round for Hookipa, a developer of immunotherapies for infectious diseases and cancer.

The artificial intelligence developer has secured seed capital of undisclosed size to commercialise its AI-based neural network platform.